Robbins LLP Is Investigating the Officers and Directors of Teligent, Inc. (TLGT) on Behalf of Shareholders
Robbins LLP is investigating whether certain officers and directors of Teligent, Inc. (NASDAQGS: TLGT) breached their fiduciary duties to shareholders. Teligent, a specialty generic pharmaceutical company, develops, formulates, manufactures, and markets generic topical and branded generic injectable pharmaceutical products in the United States and Canada.
Teligent Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.